Katherine Chiasson, MD
Plastic and Reconstructive Surgery · New Orleans, LANPI 1770842486
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,201 of the $3,223 with a category attached, or 68.3%. 14 manufacturers reported payments, led by Sientra, Inc. at 43.4% of the total. Reporting peaked in 2022 at $1,393 and has fallen 86.5% since, to $188 in 2025.
Across 43 payments — averaging $74.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sientra, Inc.$1K
- AbbVie$1K
- Acell, Inc.$98
- Organogenesis Inc.$95
- Integra Lifesciences Corporation$89
- Bard Peripheral Vascular, Inc.$87
- plus $275 from 8 others
What the payments were for
- Travel & lodging$1,02232%
- Food & beverage$2,20168%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sientra, Inc. | 8 | $1,398 |
| AbbVie(2 entities) | 20 | $1,180 |
| Acell, Inc. | 1 | $98 |
| Organogenesis Inc. | 1 | $95 |
| Integra Lifesciences Corporation | 4 | $89 |
| Bard Peripheral Vascular, Inc. | 1 | $87 |
| Merz North America, Inc. | 1 | $79 |
| Davol Inc. | 1 | $38 |
| Mentor Worldwide LLC | 1 | $37 |
| Motiva USA, LLC | 1 | $31 |
| Biocomposites Inc | 1 | $28 |
| Axogen | 1 | $25 |
| KCI USA, Inc. | 1 | $25 |
| Galderma Laboratories, L.p. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,223 in reported general payments places this provider in the 60th percentile of 45 plastic and reconstructive surgery providers in Louisiana.
See all plastic and reconstructive surgery providers in Louisiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 19 | $79 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 14 | $61 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in New Orleans
- Omer KaymakcalanNew Orleans$10K
- Suma MaddoxNew Orleans$6K
- William AukermanNew Orleans$6K
- Christopher SmithNew Orleans$5K
- Vidhur SohiniNew Orleans$5K
- Christopher BabycosNew Orleans$5K
- Daniel YooNew Orleans$4K
- Michael MosesNew Orleans$4K
- Heath CharvetNew Orleans$3K
- Stacy HendersonNew Orleans$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.